Fig. 2From: Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical statusPlasma anti-NY-ESO-1 antibody titers between aggressive and indolent ATL Plasma anti-NY-ESO-1 antibody titers were compared between aggressive (acute or lymphoma type) and indolent (chronic or smoldering) clinical subtypes of ATL by ELISA. The mean optical density value ratios were not significantly different between aggressive and indolent ATL (p = 0.738 by Mann-Whitney U test)Back to article page